Specialty Pharmacy Times: Technology and data surround us every day. From smartphones to medical records, more platforms have allowed data to be collected at a higher level. In specialty pharmacy, software platforms allow physicians to send prescriptions and manage patients without (more…)
Specialty Pharmacy Times: The health care world is largely moving towards a focus on value, rather than paying a pre-specified cost for prescription drugs that may or may not successfully treat a specific patient. This shift has important implications for manufacturers, (more…)
Specialty Pharmacy Times: Specialty drugs require increased monitoring and education provided by various health care professionals. More than ever, pharmacists are being included in innovative care teams to improve patient outcomes, especially when it comes to disease states, such as cancer. (more…)
PR NewsWire: Janssen Pharmaceuticals, Inc. today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation (AF) who are at risk for ischemic (more…)
By Blair Childs, Senior Vice President of Public Affairs, Premier Inc. Members of the Premier healthcare alliance commend House Energy and Commerce Committee Chairman Greg Walden (R-OH), Ranking Member Frank Pallone (D-NJ) and members of the Health Subcommittee for its (more…)
CHARLOTTE, N.C. (February 14, 2017) — Premier Inc., a leading healthcare improvement company, has tapped its Chief Health Information Officer, Mimi Huizinga, MD, to drive its life sciences strategy forward. A physician executive with more than ten years of quality (more…)
Modern Healthcare: Ebert, Hatcher and Premier COO Mike Alkire all said importation is only a short-term solution that ultimately could create shortages and disrupt access to medicines. Alkire said the drug industry needs more competitors in any given category in order (more…)
Health Affairs Blog: Susan DeVore: The new year is already underway and we expect both a new Republican-dominated Congress and President Donald Trump to bring ambitious policy changes to health care. With significant pent up energy among the Republicans and a (more…)
By Michael J. Alkire, COO of Premier Members of the Premier alliance commend the solicitor general for recommending the Supreme Court hear the case of Sandoz v. Amgen. This landmark case could overturn a lower court decision requiring biosimilar manufacturers (more…)
HealthcareDive: Over the past couple of years, Dr. Bimal Shah has seen dozens of value-based drug pricing contract negotiations falter. As vice president for the research division of Premier, a provider-owned healthcare improvement company, he oversees research to identify opportunities for (more…)